| 000 | 01550 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514032719.0 | ||
| 264 | 0 | _c20020718 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(02)00024-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatey, M A | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2002 |
||
| 300 |
_a1081-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aWright, J G | |
| 700 | 1 | _aAzzabi, A | |
| 700 | 1 | _aNewell, D R | |
| 700 | 1 | _aLind, M J | |
| 700 | 1 | _aCalvert, A H | |
| 700 | 1 | _aBoddy, A V | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 38 _gno. 8 _gp. 1081-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(02)00024-2 _zAvailable from publisher's website |
| 999 |
_c11906746 _d11906746 |
||